The prognosis of the neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in lung cancer and the association with treatment: a retrospective study>

j. jing (Chengdu, China)

Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Session: Lung cancer - clinical research: scientific pearls from the bedside
Session type: Thematic Poster
Number: 4213
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
j. jing (Chengdu, China). The prognosis of the neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in lung cancer and the association with treatment: a retrospective study>. 4213

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prognostic value of neutrophil to lymphocyte ratio in small cell lung cancer
Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer
Year: 2020


A meta-analysis assessing the prognostic value of neutrophil to lymphocyte ratio in lung metastasectomy for colorectal cancer
Source: Virtual Congress 2021 – Innovation in thoracic surgery
Year: 2021



LSC - 2019 - Assessment of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio as biomarkers of steroid resistance in patients with COPD
Source: International Congress 2019 – Novel molecular pathways in lung cancer and COPD
Year: 2019



Neutrophil to lymphocyte ratio and severity of COPD : prospective study
Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease
Year: 2021


Absolute neutrophil count in peripheral blood predict prognosis in lung cancer patients treated with anlotinib
Source: Virtual Congress 2021 – COVID-19 and management of lung cancer
Year: 2021

Prognostic value of neutrophil to lymphocyte ratio in patients with advanced non-small cell lung cancer
Source: Virtual Congress 2021 – Therapy of lung cancer
Year: 2021


Importance of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in COPD exacerbations
Source: International Congress 2017 – COPD and weaning
Year: 2017


Could eosinophil / neutrophil ratio be used to determine treatment in COPD patients?
Source: International Congress 2018 – Biomarkers for evaluating COPD
Year: 2018


Preoperative cell counts of white blood cell, neutrophil, lymphocyte and neutrophil/lymphocyte ratio as a predictive parameter of survival rate after complete resection for non-small cell lung cancer
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016

Does the peripheral blood neutrophil lymphocyte ratio increase as the stage of sarcoidosis progresses?
Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management
Year: 2018

Serum platelet, MPV, PCT and PDW values, neutrophil to lymphocyte and platelet to lymphocyte ratios in lung cancer diagnosis
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015


Are white blood cells count, neutrophil-to-lymphocyte ratio, lymphocyte to monocyte ratio and platelet-to-lymphocyte ratio associated with severe COVID-19 infection?
Source: Virtual Congress 2021 – COVID - 19
Year: 2021


Prognostic value of mean platelet volume in non-small cell lung cancer: a real-world, registry-based study
Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer
Year: 2019


Is there any correlation between blood neutrophil inflammatory biochemical markers and lung function impairment in COPD patients?
Source: Eur Respir J 2003; 22: Suppl. 45, 85s
Year: 2003

Prognostic value of haematological markers such as neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) in small cell lung cancer.
Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer
Year: 2020


The role of angiogenesis, assessed by microvessel count (MVC), on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis
Source: Eur Respir J 2002; 20: Suppl. 38, 3s
Year: 2002

Relationship between blood monocyte subsets with activation markers and macrophages in non-small cell lung cancer
Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer
Year: 2020


Clinical significance of blood neutrophil differential count in patients with COPD
Source: International Congress 2017 – Biomarker-based asthma control
Year: 2017

The increase of circulating B7-H4-expressing CD68+ macrophage correlated with clinical stage of lung carcinomas
Source: Annual Congress 2012 - Prognosis of lung cancer
Year: 2012

The meaning of a high monocyte to lymphocyte ratio in tuberculosis
Source: International Congress 2019 – Tuberculosis: diagnosis and scores
Year: 2019